Când cancerul hepatic primar este asociat cu ascită, icter, metastaze la distanță etc., se numește cancer hepatic primar avansat. Tratamentul cancerului hepatic primar avansat este dificil, iar efectul tratamentului clinic nu este ideal. Chirurgia nu este o opțiune pentru tratarea cancerului hepatic avansat, deoarece s-a răspândit la ganglionii limfatici sau la alte organe.
If the liver is in good condition (Child-Pugh grade A or B), the doctor will consider treatment with the targeted therapeutic drugs Sorafenib (Nexavar) or Lenvama (Lenvima). Growth can prolong the survival time of patients. If the patient develops drug resistance, the targeted drug repaglinide (Stivarga) or the imunoterapia drug nivolumab (Opdivo) can be used instead.
In addition, keeping an eye on clinical trial information at any time and actively participating in relevant clinical trials such as chemotherapy, radiotherapy, and immunotherapy may also bring opportunities and hope for patients with advanced cancer de ficat. It is hoped that in the next few years, researchers will make a huge breakthrough in the field of liver cancer diagnosis and treatment.
